Coromandel International Limited announced its financial results for the quarter and half-year ended September 30, 2026. The company reported a 6% revenue growth for the quarter and 10% for the half-year. However, EBITDA declined by 21% in Q2 and 19% in H1, primarily due to margin pressure in the fertiliser business driven by rising raw material costs and subsidies not fully covering the increase.
Coromandel International Q2 FY27 Financial Highlights
Coromandel International Limited, a leading agri-solutions provider, has announced its financial results for the second quarter (Q2) and the first half-year (H1) of the fiscal year 2027, ending on September 30, 2026. The company demonstrated revenue growth across its operations, yet faced profitability challenges.
Q2 FY27 Performance Summary
Standalone Results
For the standalone Q2 FY27, Coromandel International reported a Total Income of ₹9,987 crore, an increase of 5% compared to ₹9,513 crore in Q2 FY26. However, EBITDA saw a significant decrease of 21%, falling to ₹904 crore from ₹1,147 crore in the previous year. Profit Before Tax (PBT) declined by 33% to ₹737 crore, and Profit After Tax (PAT) also dropped by 33% to ₹548 crore.
Consolidated Results
On a consolidated basis, the Total Income for Q2 FY27 rose by 6% to ₹10,348 crore from ₹9,771 crore in Q2 FY26. Consolidated EBITDA decreased by 18% to ₹944 crore (from ₹1,147 crore). Consolidated PBT was down 33% to ₹706 crore, and PAT fell by 34% to ₹523 crore.
H1 FY27 Performance Summary
Standalone Results
In the first half of FY27, standalone Total Income grew by 7% to ₹17,779 crore. EBITDA decreased by 19% to ₹1,530 crore. Standalone PBT and PAT both declined by 30%, to ₹1,242 crore and ₹925 crore respectively.
Consolidated Results
Consolidated Total Income for H1 FY27 increased by 10% to ₹18,563 crore. Consolidated EBITDA saw a reduction of 12% to ₹1,705 crore. Consolidated PBT and PAT also dropped by 30%, reaching ₹1,220 crore and ₹905 crore respectively.
Key Business Drivers and Commentary
The company attributed the revenue growth to its diversified portfolio and strategic initiatives. However, the decline in profitability was largely due to margin pressures in the Fertiliser business. This was exacerbated by increased raw material costs, stemming from the ongoing Middle East crisis, which were not fully compensated by subsidies. Mr. S. Sankarasubramanian, Managing Director & CEO, commented on the resilient performance amidst a challenging environment, highlighting the company’s focus on differentiated offerings and the launch of ten new products in the Nutrients and Crop Protection segments.
Strategic Initiatives Update
Coromandel’s long-term strategic initiatives are progressing as planned. The new NPK fertiliser capacity is on track for completion by Q4 FY27. In Crop Protection, additional capacity for a key molecule is expected by Q3. The Company is also establishing a launch plant for fluoro intermediates to support R&D commercialization and enhance specialty chemistry capabilities. The Retail business expanded its network with close to 100 new stores during the quarter, bringing the total to over 1300 stores.
Business Segment Performance
The Fertiliser business faced headwinds from deficit rainfall and elevated raw material prices, impacting offtake and margins. Despite this, the company supplied approximately 3.3 million tons of fertilisers in H1, strengthening its leadership in the phosphatic segment with a market share increase to 19%. The newly commissioned Phosphoric acid and sulphuric acid plant at Kakinada is helping mitigate supply disruptions. The Crop Protection business recorded a 22% revenue growth, driven by strong export performance and a focus on differentiated products in the domestic market. The Retail business widened its reach, with its speciality nutrients, organic, and biological segments showing strong performance due to increasing farmer adoption of sustainable solutions.
Source: BSE
